The global Adults Genetic Disease Diagnosis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Adult genetic disease diagnosis involves testing to identify genetic disorders that manifest later in life. This can include conditions like Huntington's disease, certain types of cancer, or hereditary heart diseases. Methods often include blood tests, genetic sequencing, and family history assessments, enabling healthcare providers to offer personalized treatment and management plans.

The North American market for Adults Genetic Disease Diagnosis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Adults Genetic Disease Diagnosis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Adults Genetic Disease Diagnosis in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Adults Genetic Disease Diagnosis include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Adults Genetic Disease Diagnosis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Adults Genetic Disease Diagnosis. The Adults Genetic Disease Diagnosis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Adults Genetic Disease Diagnosis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Adults Genetic Disease Diagnosis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Adults Genetic Disease Diagnosis Market Report

Report Metric	Details
Report Name	Adults Genetic Disease Diagnosis Market
Segment by Type	Prenatal Diagnosis Screening for Single Gene Genetic Disease Preimplantation Genetic Testing Others
Segment by Application	Hospital Medical Laboratory Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Adults Genetic Disease Diagnosis companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Adults Genetic Disease Diagnosis Market report?

Ans: The main players in the Adults Genetic Disease Diagnosis Market are Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology

What are the Application segmentation covered in the Adults Genetic Disease Diagnosis Market report?

Ans: The Applications covered in the Adults Genetic Disease Diagnosis Market report are Hospital, Medical Laboratory, Others

What are the Type segmentation covered in the Adults Genetic Disease Diagnosis Market report?

Ans: The Types covered in the Adults Genetic Disease Diagnosis Market report are Prenatal Diagnosis, Screening for Single Gene Genetic Disease, Preimplantation Genetic Testing, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Prenatal Diagnosis

1.2.3 Screening for Single Gene Genetic Disease

1.2.4 Preimplantation Genetic Testing

1.2.5 Others

1.3 Market by Application

1.3.1 Global Adults Genetic Disease Diagnosis Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Medical Laboratory

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Adults Genetic Disease Diagnosis Market Perspective (2021–2032)

2.2 Global Adults Genetic Disease Diagnosis Growth Trends by Region

2.2.1 Global Adults Genetic Disease Diagnosis Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Adults Genetic Disease Diagnosis Historic Market Size by Region (2021–2026)

2.2.3 Adults Genetic Disease Diagnosis Forecasted Market Size by Region (2027–2032)

2.3 Adults Genetic Disease Diagnosis Market Dynamics

2.3.1 Adults Genetic Disease Diagnosis Industry Trends

2.3.2 Adults Genetic Disease Diagnosis Market Drivers

2.3.3 Adults Genetic Disease Diagnosis Market Challenges

2.3.4 Adults Genetic Disease Diagnosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Adults Genetic Disease Diagnosis Players by Revenue

3.1.1 Global Top Adults Genetic Disease Diagnosis Players by Revenue (2021–2026)

3.1.2 Global Adults Genetic Disease Diagnosis Revenue Market Share by Players (2021–2026)

3.2 Global Top Adults Genetic Disease Diagnosis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Adults Genetic Disease Diagnosis Revenue

3.4 Global Adults Genetic Disease Diagnosis Market Concentration Ratio

3.4.1 Global Adults Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adults Genetic Disease Diagnosis Revenue in 2025

3.5 Global Key Players of Adults Genetic Disease Diagnosis Head Offices and Areas Served

3.6 Global Key Players of Adults Genetic Disease Diagnosis, Products and Applications

3.7 Global Key Players of Adults Genetic Disease Diagnosis, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Adults Genetic Disease Diagnosis Breakdown Data by Type

4.1 Global Adults Genetic Disease Diagnosis Historic Market Size by Type (2021–2026)

4.2 Global Adults Genetic Disease Diagnosis Forecasted Market Size by Type (2027–2032)

5 Adults Genetic Disease Diagnosis Breakdown Data by Application

5.1 Global Adults Genetic Disease Diagnosis Historic Market Size by Application (2021–2026)

5.2 Global Adults Genetic Disease Diagnosis Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Adults Genetic Disease Diagnosis Market Size (2021–2032)

6.2 North America Adults Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Adults Genetic Disease Diagnosis Market Size by Country (2021–2026)

6.4 North America Adults Genetic Disease Diagnosis Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Adults Genetic Disease Diagnosis Market Size (2021–2032)

7.2 Europe Adults Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Adults Genetic Disease Diagnosis Market Size by Country (2021–2026)

7.4 Europe Adults Genetic Disease Diagnosis Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Adults Genetic Disease Diagnosis Market Size (2021–2032)

8.2 Asia-Pacific Adults Genetic Disease Diagnosis Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Region (2021–2026)

8.4 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Adults Genetic Disease Diagnosis Market Size (2021–2032)

9.2 Latin America Adults Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Adults Genetic Disease Diagnosis Market Size by Country (2021–2026)

9.4 Latin America Adults Genetic Disease Diagnosis Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Adults Genetic Disease Diagnosis Market Size (2021–2032)

10.2 Middle East & Africa Adults Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Adults Genetic Disease Diagnosis Market Size by Country (2021–2026)

10.4 Middle East & Africa Adults Genetic Disease Diagnosis Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Adults Genetic Disease Diagnosis Introduction

11.1.4 Abbott Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.1.5 Abbott Recent Development

11.2 PerkinElmer

11.2.1 PerkinElmer Company Details

11.2.2 PerkinElmer Business Overview

11.2.3 PerkinElmer Adults Genetic Disease Diagnosis Introduction

11.2.4 PerkinElmer Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.2.5 PerkinElmer Recent Development

11.3 Roche Diagnostics

11.3.1 Roche Diagnostics Company Details

11.3.2 Roche Diagnostics Business Overview

11.3.3 Roche Diagnostics Adults Genetic Disease Diagnosis Introduction

11.3.4 Roche Diagnostics Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.3.5 Roche Diagnostics Recent Development

11.4 Bio Rad

11.4.1 Bio Rad Company Details

11.4.2 Bio Rad Business Overview

11.4.3 Bio Rad Adults Genetic Disease Diagnosis Introduction

11.4.4 Bio Rad Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.4.5 Bio Rad Recent Development

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Details

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Introduction

11.5.4 Thermo Fisher Scientific Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.5.5 Thermo Fisher Scientific Recent Development

11.6 BGI Group

11.6.1 BGI Group Company Details

11.6.2 BGI Group Business Overview

11.6.3 BGI Group Adults Genetic Disease Diagnosis Introduction

11.6.4 BGI Group Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.6.5 BGI Group Recent Development

11.7 Berry Genomics

11.7.1 Berry Genomics Company Details

11.7.2 Berry Genomics Business Overview

11.7.3 Berry Genomics Adults Genetic Disease Diagnosis Introduction

11.7.4 Berry Genomics Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.7.5 Berry Genomics Recent Development

11.8 Da An Gene Co., Ltd.

11.8.1 Da An Gene Co., Ltd. Company Details

11.8.2 Da An Gene Co., Ltd. Business Overview

11.8.3 Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Introduction

11.8.4 Da An Gene Co., Ltd. Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.8.5 Da An Gene Co., Ltd. Recent Development

11.9 Illumina

11.9.1 Illumina Company Details

11.9.2 Illumina Business Overview

11.9.3 Illumina Adults Genetic Disease Diagnosis Introduction

11.9.4 Illumina Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.9.5 Illumina Recent Development

11.10 CapitalBio Technology

11.10.1 CapitalBio Technology Company Details

11.10.2 CapitalBio Technology Business Overview

11.10.3 CapitalBio Technology Adults Genetic Disease Diagnosis Introduction

11.10.4 CapitalBio Technology Revenue in Adults Genetic Disease Diagnosis Business (2021–2026)

11.10.5 CapitalBio Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CapitalBio Technology

List of Tables

Table 1. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Prenatal Diagnosis

Table 3. Key Players of Screening for Single Gene Genetic Disease

Table 4. Key Players of Preimplantation Genetic Testing

Table 5. Key Players of Others

Table 6. Global Adults Genetic Disease Diagnosis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Adults Genetic Disease Diagnosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Adults Genetic Disease Diagnosis Market Size by Region (US$ Million), 2021–2026

Table 9. Global Adults Genetic Disease Diagnosis Market Share by Region (2021–2026)

Table 10. Global Adults Genetic Disease Diagnosis Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Adults Genetic Disease Diagnosis Market Share by Region (2027–2032)

Table 12. Adults Genetic Disease Diagnosis Market Trends

Table 13. Adults Genetic Disease Diagnosis Market Drivers

Table 14. Adults Genetic Disease Diagnosis Market Challenges

Table 15. Adults Genetic Disease Diagnosis Market Restraints

Table 16. Global Adults Genetic Disease Diagnosis Revenue by Players (US$ Million), 2021–2026

Table 17. Global Adults Genetic Disease Diagnosis Market Share by Players (2021–2026)

Table 18. Global Top Adults Genetic Disease Diagnosis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Adults Genetic Disease Diagnosis Revenue, 2025

Table 19. Ranking of Global Top Adults Genetic Disease Diagnosis Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Adults Genetic Disease Diagnosis Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Adults Genetic Disease Diagnosis, Headquarters and Area Served

Table 22. Global Key Players of Adults Genetic Disease Diagnosis, Products and Applications

Table 23. Global Key Players of Adults Genetic Disease Diagnosis, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Adults Genetic Disease Diagnosis Market Size by Type (US$ Million), 2021–2026

Table 26. Global Adults Genetic Disease Diagnosis Revenue Market Share by Type (2021–2026)

Table 27. Global Adults Genetic Disease Diagnosis Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Adults Genetic Disease Diagnosis Revenue Market Share by Type (2027–2032)

Table 29. Global Adults Genetic Disease Diagnosis Market Size by Application (US$ Million), 2021–2026

Table 30. Global Adults Genetic Disease Diagnosis Revenue Market Share by Application (2021–2026)

Table 31. Global Adults Genetic Disease Diagnosis Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Adults Genetic Disease Diagnosis Revenue Market Share by Application (2027–2032)

Table 33. North America Adults Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 35. North America Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Adults Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Adults Genetic Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Adults Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Adults Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Adults Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 48. Abbott Company Details

Table 49. Abbott Business Overview

Table 50. Abbott Adults Genetic Disease Diagnosis Product

Table 51. Abbott Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 52. Abbott Recent Development

Table 53. PerkinElmer Company Details

Table 54. PerkinElmer Business Overview

Table 55. PerkinElmer Adults Genetic Disease Diagnosis Product

Table 56. PerkinElmer Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 57. PerkinElmer Recent Development

Table 58. Roche Diagnostics Company Details

Table 59. Roche Diagnostics Business Overview

Table 60. Roche Diagnostics Adults Genetic Disease Diagnosis Product

Table 61. Roche Diagnostics Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 62. Roche Diagnostics Recent Development

Table 63. Bio Rad Company Details

Table 64. Bio Rad Business Overview

Table 65. Bio Rad Adults Genetic Disease Diagnosis Product

Table 66. Bio Rad Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 67. Bio Rad Recent Development

Table 68. Thermo Fisher Scientific Company Details

Table 69. Thermo Fisher Scientific Business Overview

Table 70. Thermo Fisher Scientific Adults Genetic Disease Diagnosis Product

Table 71. Thermo Fisher Scientific Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 72. Thermo Fisher Scientific Recent Development

Table 73. BGI Group Company Details

Table 74. BGI Group Business Overview

Table 75. BGI Group Adults Genetic Disease Diagnosis Product

Table 76. BGI Group Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 77. BGI Group Recent Development

Table 78. Berry Genomics Company Details

Table 79. Berry Genomics Business Overview

Table 80. Berry Genomics Adults Genetic Disease Diagnosis Product

Table 81. Berry Genomics Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 82. Berry Genomics Recent Development

Table 83. Da An Gene Co., Ltd. Company Details

Table 84. Da An Gene Co., Ltd. Business Overview

Table 85. Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Product

Table 86. Da An Gene Co., Ltd. Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 87. Da An Gene Co., Ltd. Recent Development

Table 88. Illumina Company Details

Table 89. Illumina Business Overview

Table 90. Illumina Adults Genetic Disease Diagnosis Product

Table 91. Illumina Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 92. Illumina Recent Development

Table 93. CapitalBio Technology Company Details

Table 94. CapitalBio Technology Business Overview

Table 95. CapitalBio Technology Adults Genetic Disease Diagnosis Product

Table 96. CapitalBio Technology Revenue in Adults Genetic Disease Diagnosis Business (US$ Million), 2021–2026

Table 97. CapitalBio Technology Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Adults Genetic Disease Diagnosis Picture

Figure 2. Global Adults Genetic Disease Diagnosis Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Adults Genetic Disease Diagnosis Market Share by Type: 2025 vs 2032

Figure 4. Prenatal Diagnosis Features

Figure 5. Screening for Single Gene Genetic Disease Features

Figure 6. Preimplantation Genetic Testing Features

Figure 7. Others Features

Figure 8. Global Adults Genetic Disease Diagnosis Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Adults Genetic Disease Diagnosis Market Share by Application: 2025 vs 2032

Figure 10. Hospital Case Studies

Figure 11. Medical Laboratory Case Studies

Figure 12. Others Case Studies

Figure 13. Adults Genetic Disease Diagnosis Report Years Considered

Figure 14. Global Adults Genetic Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Adults Genetic Disease Diagnosis Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Adults Genetic Disease Diagnosis Market Share by Region: 2025 vs 2032

Figure 17. Global Adults Genetic Disease Diagnosis Market Share by Players in 2025

Figure 18. Global Adults Genetic Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Adults Genetic Disease Diagnosis Revenue in 2025

Figure 20. North America Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Adults Genetic Disease Diagnosis Market Share by Country (2021–2032)

Figure 22. United States Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Adults Genetic Disease Diagnosis Market Share by Country (2021–2032)

Figure 26. Germany Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Adults Genetic Disease Diagnosis Market Share by Region (2021–2032)

Figure 34. China Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Adults Genetic Disease Diagnosis Market Share by Country (2021–2032)

Figure 42. Mexico Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Adults Genetic Disease Diagnosis Market Share by Country (2021–2032)

Figure 46. Israel Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Adults Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Abbott Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 50. PerkinElmer Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 51. Roche Diagnostics Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 52. Bio Rad Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 54. BGI Group Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 55. Berry Genomics Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 56. Da An Gene Co., Ltd. Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 57. Illumina Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 58. CapitalBio Technology Revenue Growth Rate in Adults Genetic Disease Diagnosis Business (2021–2026)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions